- US-listed companies
- SOLENO THERAPEUTICS INC
- Income statement
SOLENO THERAPEUTICS INC (SLNO) Income statement
Market cap
$1.9B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | - | 607,472 | 1 | - | - | - | - | - | - | - | - |
| Revenue growth (%) | - | - | - | - | - | - | - | - | - | - | |
| Cost of revenue | - | 352,683 | 2 | - | - | - | - | - | - | - | - |
| Gross profit | - | 254,789 | -58,518 | - | - | - | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | - | - | - | - | ||
| Research & development | 2 | 5 | 5 | 3 | 7 | 16 | 23 | 21 | 15 | 25 | 79 |
| Operating margin (%) | - | - | - | - | - | - | - | - | - | ||
| Operating expenses | 5 | 12 | 14 | 12 | 14 | 23 | 36 | 32 | 24 | 41 | 188 |
| Operating income | -5,159,729 | -12,159,746 | -13,610,115 | -12,171,315 | -14 | -23 | -36 | -32 | -24 | -41 | -188 |
| Income before tax | - | - | -12,043,514 | -13,724,317 | -12 | - | - | - | - | - | - |
| Pretax margin (%) | - | - | -830.1 | - | - | - | - | - | - | - | - |
| Provision for income taxes | - | - | 21,700 | -1,650,467 | - | - | - | - | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | ||
| Net income | -13,874,513 | -15,908,546 | -12,065,214 | -15,667,425 | -13 | -31 | -25 | -31 | -24 | -39 | -176 |
| Net income margin (%) | - | - | - | - | - | - | - | - | - | ||
| Earnings per share | - | - | - | - | - | - | - | - | -2.87 | -2.36 | -4.38 |
| Diluted EPS | - | - | - | - | - | - | - | - | -2.87 | -2.36 | -4.38 |